Madrigal Pharmaceuticals Inc (MDGL)
210.82
+6.80
(+3.33%)
USD |
NASDAQ |
May 01, 16:00
210.82
0.00 (0.00%)
After-Hours: 20:00
Madrigal Pharmaceuticals Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
March 31, 2012 | 0.4877 |
December 31, 2011 | 1.125 |
September 30, 2011 | 0.6821 |
June 30, 2011 | 0.464 |
March 31, 2011 | 1.298 |
December 31, 2010 | 0.4969 |
September 30, 2010 | 0.5077 |
June 30, 2010 | 0.00 |
March 31, 2010 | 0.00 |
December 31, 2009 | 0.00 |
September 30, 2009 | 0.00 |
June 30, 2009 | 0.00 |
March 31, 2009 | -0.1053 |
December 31, 2008 | 0.00 |
September 30, 2008 | -0.0696 |
Date | Value |
---|---|
June 30, 2008 | -0.252 |
March 31, 2008 | 0.2239 |
December 31, 2007 | 0.0966 |
September 30, 2007 | 0.0632 |
June 30, 2007 | 0.0465 |
March 31, 2007 | 0.0352 |
December 31, 2006 | -1.334 |
September 30, 2006 | 0.2192 |
June 30, 2006 | |
March 31, 2006 | |
December 31, 2005 | 0.0365 |
September 30, 2005 | |
June 30, 2005 | |
March 31, 2005 | 0.0074 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
Eli Lilly and Co | 2.342 |
Viking Therapeutics Inc | -- |
Akero Therapeutics Inc | -- |
89bio Inc | -- |
Geron Corp | 0.3305 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 640.55M |
Total Liabilities (Quarterly) | 235.21M |
Shareholders Equity (Quarterly) | 405.33M |